Literature DB >> 11382587

The receptor tyrosine kinases: role in cancer progression.

L Lamorte1, M Park.   

Abstract

The last two decades have witnessed significant progress in the understanding of the basic mechanisms underlying tumor growth and metastasis. Receptor tyrosine kinases play a central role in cell proliferation and differentiation, cell survival, cell motility, invasion, and angiogenesis, all of which contribute to tumor progression. Alterations at the level of the receptor and its ligand lead to the activation of a number of signaling pathways, each of which may contribute to cancer progression. The dissection of the molecular changes associated with neoplastic growth have provided pharmaceutical companies with a range of targets for drug intervention. This article highlights the deregulation of receptor tyrosine kinases in human cancers and their involvement in metastasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11382587

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  15 in total

1.  Oncogenic targeting of an activated tyrosine kinase to the Golgi apparatus in a glioblastoma.

Authors:  Alan Charest; Vicky Kheifets; Julie Park; Keara Lane; Kevin McMahon; Cathy L Nutt; David Housman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

2.  Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA).

Authors:  Michael J Wagner; Rahul Mitra; Mark J McArthur; Wallace Baze; Kirstin Barnhart; Sherry Y Wu; Cristian Rodriguez-Aguayo; Xinna Zhang; Robert L Coleman; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Mol Cancer Ther       Date:  2017-03-06       Impact factor: 6.261

3.  A Nonsynonymous Variant in the GOLM1 Gene in Cutaneous Malignant Melanoma.

Authors:  Craig C Teerlink; Chad Huff; Jeff Stevens; Yao Yu; Sheri L Holmen; Mark R Silvis; Kirby Trombetti; Hua Zhao; Douglas Grossman; James M Farnham; Jingran Wen; Julio C Facelli; Alun Thomas; Markus Babst; Scott R Florell; Laurence Meyer; John J Zone; Sancy Leachman; Lisa A Cannon-Albright
Journal:  J Natl Cancer Inst       Date:  2018-12-01       Impact factor: 13.506

4.  Structural Basis of TPR-Mediated Oligomerization and Activation of Oncogenic Fusion Kinases.

Authors:  Kuntal Pal; Abhishek Bandyopadhyay; X Edward Zhou; Qingping Xu; David P Marciano; Joseph S Brunzelle; Smitha Yerrum; Patrick R Griffin; George Vande Woude; Karsten Melcher; H Eric Xu
Journal:  Structure       Date:  2017-05-18       Impact factor: 5.006

5.  Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctions.

Authors:  Louie Lamorte; Isabelle Royal; Monica Naujokas; Morag Park
Journal:  Mol Biol Cell       Date:  2002-05       Impact factor: 4.138

6.  Effects of the tyrosine protein kinase inhibitor genistein on the proliferation, activation of cultured rat hepatic stellate cells.

Authors:  Xiao-Jing Liu; Li Yang; Yong-Qiu Mao; Qiong Wang; Ming-Hui Huang; Yi-Ping Wang; Hong-Bin Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

7.  GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis.

Authors:  Qing-Hai Ye; Wen-Wei Zhu; Ju-Bo Zhang; Yi Qin; Ming Lu; Guo-Ling Lin; Lei Guo; Bo Zhang; Zhen-Hai Lin; Stephanie Roessler; Marshonna Forgues; Hu-Liang Jia; Lu Lu; Xiao-Fei Zhang; Bao-Feng Lian; Lu Xie; Qiong-Zhu Dong; Zhao-You Tang; Xin Wei Wang; Lun-Xiu Qin
Journal:  Cancer Cell       Date:  2016-08-25       Impact factor: 31.743

8.  Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field.

Authors:  Fernanda Ledda; Gustavo Paratcha
Journal:  Biomark Insights       Date:  2007-02-14

9.  EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer.

Authors:  Aparna A Kamat; Donna Coffey; William M Merritt; Elizabeth Nugent; Diana Urbauer; Yvonne G Lin; Creighton Edwards; Russell Broaddus; Robert L Coleman; Anil K Sood
Journal:  Cancer       Date:  2009-06-15       Impact factor: 6.860

10.  Detection of MET and SOX2 amplification by quantitative real-time PCR in non-small cell lung carcinoma.

Authors:  Yi-Ran Cai; Hai-Qing Zhang; Zong-DE Zhang; Jing Mu; Zi-Hui Li
Journal:  Oncol Lett       Date:  2010-12-23       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.